More affordable generic drugs for Montana, that's what the goal of a law sponsored by Sen. Steve Daines, R-MT., is trying to do. The Creating and Restoring Equal Access to Equivalent Samples Act is trying to get bipartisan support to combat brand-name drug manufacturers’ attempts to delay competition from more affordable generic drugs.

“Keeping the market competitive will increase Montanans’ access to safe, affordable drugs,” said Daines.

The Creating and Restoring Equal Access to Equivalent Samples Act will target what some say are abusive delay tactics that keep affordable generic drugs from entering the market.

The new law would let generic drug manufacturers bring action in federal court. So, when a brand-name drug company tries to block generic competitors from obtaining necessary samples to show product equivalency for FDA approval, the legal system would come into play.

Dominick